[18F]FDG PET-CT in patients with DLBCL treated with CAR-T cell therapy: a practical approach of reporting pre- and post-treatment studies.

Dan Cohen Efrat LuttwakOfrat Beyar-KatzShir Hazut KrauthammerYael Bar-OnOdelia AmitRonit GoldChava PerryIrit Avivi Ron Ram Einat Even-Sapir

Published in: European journal of nuclear medicine and molecular imaging (2021)

Pre-treatment SUVmax may guide patient selection for CAR-T therapy. On M1-PET-CT, Deauville score and ΔSUVmax from TD may identify early therapy failure. These parameters are easy to obtain and should be included in the PET-CT report.

Keyphrases

pet ct
cell therapy
positron emission tomography
stem cells
emergency department
diffuse large b cell lymphoma
case report
adverse drug
replacement therapy
electronic health record